Astera Labs (NASDAQ:ALAB) Hits New 1-Year High – What’s Next?

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $456.76 and last traded at $455.96, with a volume of 6267145 shares. The stock had previously closed at $391.74.

Analyst Upgrades and Downgrades

ALAB has been the topic of several analyst reports. Citigroup lowered shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Evercore restated an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Finally, Rothschild & Co Redburn started coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $265.75.

View Our Latest Analysis on ALAB

Astera Labs Price Performance

The firm has a market cap of $78.16 billion, a PE ratio of 308.08, a price-to-earnings-growth ratio of 4.50 and a beta of 3.94. The stock’s fifty day moving average price is $294.90 and its 200-day moving average price is $198.27.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period last year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. This represents a 0.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161,942 shares of company stock worth $460,115,294 over the last quarter. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the stock. Eurizon Capital SGR S.p.A. purchased a new position in shares of Astera Labs in the 4th quarter valued at about $18,708,000. Nordea Investment Management AB purchased a new stake in Astera Labs during the fourth quarter worth approximately $2,028,000. Geneva Partners LLC purchased a new stake in Astera Labs during the third quarter worth approximately $1,876,000. Swedbank AB boosted its holdings in Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares in the last quarter. Finally, Numerai GP LLC boosted its holdings in Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.